|Grant Affiliation:||Pantaleo: RepliVax Vaccine Platform|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2015-01-07|
|Study Made Public:||2015-10-22|
Comparison of affinity and neutralizing capacity of unlabeled and labeled broadly neutralizing antibodies to HIV-1 Envelope
CAVD 476 is an immunogenicity study of broadly neutralizing antibodies.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No non-integrated data is available for this study.